Free Trial

Janux Therapeutics (JANX) Insider Trading & Ownership

Janux Therapeutics logo
$48.00 -0.82 (-1.68%)
(As of 11/26/2024 ET)

Janux Therapeutics (NASDAQ:JANX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
29.40%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$53.70 M
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$183.54 M
Get JANX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Janux Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

JANX Insider Buying and Selling by Quarter

Janux Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/28/2024David Alan CampbellCEOSell25,000$53.54$1,338,500.00  
10/18/2024Ra Capital Management, L.P.DirectorBuy1,200,000$44.75$53,700,000.00  
10/17/2024Ventures Xi L.P. AvalonMajor ShareholderSell1,843$50.02$92,186.86  
9/30/2024Ventures Xi L.P. AvalonMajor ShareholderSell958$46.24$44,297.92  
9/27/2024Andrew Hollman MeyerInsiderSell50,000$45.96$2,298,000.00  
9/27/2024David Alan CampbellCEOSell25,000$46.31$1,157,750.00  
Crypto’s next big bull run? (Ad)

Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on November 5. Just a day after the American election, Juan believes crypto could start a massive run up …

And one special coin could do even better.
9/27/2024Ventures Xi L.P. AvalonMajor ShareholderSell49,231$46.45$2,286,779.95  
9/12/2024Ventures Xi L.P. AvalonMajor ShareholderSell158,031$47.00$7,427,457.00  
9/9/2024Ventures Xi L.P. AvalonMajor ShareholderSell2,182$42.33$92,364.06  
9/6/2024Ventures Xi L.P. AvalonMajor ShareholderSell108,365$42.00$4,551,330.00  
6/3/2024Jay LichterDirectorSell1,500,000$54.75$82,125,000.00  
6/3/2024Tighe ReardonCFOSell822,721$54.75$45,043,974.75  
6/3/2024Ventures Xi L.P. AvalonMajor ShareholderSell677,279$54.75$37,081,025.25  
(Data available from 1/1/2013 forward)

JANX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Janux Therapeutics includes Andrew Hollman Meyer, David Alan Campbell, Jay Lichter, Ra Capital Management, L.P., Tighe Reardon, and Ventures Xi L.P. Avalon. Learn more on insiders at JANX.

29.40% of Janux Therapeutics stock is owned by insiders. Learn more on JANX's insider holdings.

The following insiders have purchased JANX shares in the last 24 months: Ra Capital Management, L.P. ($59,867,799.68), and Ventures Xi L.P. Avalon ($4,988,642.98).

Insiders have purchased a total of 2,544,862 JANX shares in the last 24 months for a total of $64,856,442.66 bought.

The following insiders have sold JANX shares in the last 24 months: Andrew Hollman Meyer ($2,298,000.00), David Alan Campbell ($2,496,250.00), Jay Lichter ($82,125,000.00), Tighe Reardon ($45,043,974.75), and Ventures Xi L.P. Avalon ($51,575,441.04).

Insiders have sold a total of 3,420,610 Janux Therapeutics shares in the last 24 months for a total of $183,538,665.79 sold.

Janux Therapeutics Key Executives

  • Dr. David Alan Campbell Ph.D. (Age 64)
    President, CEO & Director
    Compensation: $1.04M
  • Mr. Charles M. Winter (Age 55)
    Chief Technical Officer
    Compensation: $590.4k
  • Mr. Byron Robinson J.D. (Age 59)
    Ph.D., Chief Strategy Officer
    Compensation: $723k
  • Mr. Tighe M. Reardon C.F.A. (Age 48)
    CPA, Acting Chief Financial Officer
  • Dr. Tommy Diraimondo Ph.D. (Age 38)
    Chief Scientific Officer
  • Mr. James Pennington
    General Counsel
  • Ms. Brenda Van Vreeswyk
    Head of Human Resources
  • Mr. Andy Hollman MeyerMr. Andy Hollman Meyer (Age 40)
    Chief Business Officer
    1 recent trades


This page (NASDAQ:JANX) was last updated on 11/26/2024 by MarketBeat.com Staff
From Our Partners